对三抗真菌药物的营销后药监测研究:基于FDA不良事件报告系统数据库的不良事件数据挖掘和分析
Yalan Tian1, Min Jin1, Hong Ning1
1Department of Pharmacy, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.
Frontiers in pharmacology
|February 7, 2025
概括
这项研究分析了voriconazole,posaconazole和isavuconazole的不良药物事件. 沃里康纳显示眼睛和神经系统疾病的风险更高,在所有三种抗真菌药物中都发现了新的信号.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 临床药理学 临床药理学
背景情况:
- 沃里康纳,波萨康纳和伊萨武康纳是重要的抗真菌剂.
- 了解它们的营销后安全概况对于临床决策至关重要.
研究的目的:
- 分析和比较市场营销后不良药物事件 (ADE) 信号对沃里康纳,波萨康纳和伊萨武康纳.
- 确定安全差异,并为这些醇抗真菌剂的合理临床使用提供见解.
主要方法:
- 使用Open Vigil 2.1工具从FDA FAERS数据库中提取ADE数据 (直到2023年第三季度).
- 对于信号检测,雇员报告几率比率 (ROR) 和比例报告比率 (PRR).
- 使用MedDRA 26.0.0按系统器官类 (SOC) 分类识别的ADE信号.
主要成果:
- 分析了8,898份沃里康纳的ADE报告,1948份波萨康纳和944份伊萨武康纳的ADE报告.
- 确定了607个独特的ADE信号:沃里康纳的402个,波萨康纳的159个和伊萨武康纳的46个.
- 沃里康纳的ADEs经常涉及调查,眼部疾病和神经系统疾病; 波萨康纳涉及调查和一般疾病; 伊萨夫康纳涉及一般疾病和肝胆道疾病.
结论:
- 沃里康纳,波萨康纳和伊萨武康纳共享肝胆道和心脏疾病的潜在风险.
- 沃里康纳对眼睛和神经系统疾病的安全性存在更大的担忧.
- 新的ADE信号包括伏利康纳诱导的拉布多米解,波萨康纳诱导的外周神经病变,以及易萨武康纳诱导的视力障碍和精神混乱,为临床实践提供了信息.
相关概念视频
Pharmacovigilance
769
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
769
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K


